Justice Dept. Eases Marijuana Regs, Boosts Medical Ops

0:00It's April 24th. This is Anchorage News today, AI-powered stories from your city. The Justice Department just dropped a big move on marijuana rigs. State legal medical cannabis products shift from schedule one, the no-go zone, with stuff like heroin to schedule three, easing up on taxes and research. For legit businesses, this hits 40 states plus DC, where medical use is greenlit, letting companies deduct expenses and scientists study real-world supply. It stems from President Trump's push last year to rethink federal rules. Acting A.G. Todd Blanch called it a win for patient access and better medical info. No change yet for banking woes, though. Those money-wondering risks still hang over lenders dealing with any cannabis biz. Folks in the industry are buzzing. Advocates hail it as historic, finally nodding to medical marijuana's legitimacy after decades of federal pushback. These leaders say it kills stigma, sparks more research, and pulls in big banks eventually, but hybrid shops mixing medical and rec sales, face tax, headaches on the fun side.

1:04A DEA hearing kicks off June 29th through mid-July to eye full rescheduling, maybe even recreational stuff. That's the next big step toward wiping pot off the danger list entirely. For now, this car bout boost medical ops without touching adult use, but expect regulators to blend lines over time as the plants the same, regardless. Change is rolling in slow, but steady.